mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
CI-976 |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
UNC0321 |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.2 |
mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.2 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
BRD-K51490254 |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
YL54 |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.2 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.2 |